The assay and significance of CXCL16 in serum of hepatitis B patients.
-
摘要: 目的探讨乙肝患者血清趋化因子CXCL16的变化规律及其临床意义。方法用酶联免疫吸附法(ELISA)检测血清CXCL16浓度;荧光定量聚合酶链反应法(FQ-PCR)检测HBV-DNA;全自动生化仪检测肝功能。结果对照组(n=25)、急性乙肝组(n=24)、慢性乙肝组(n=32)CXCL16浓度分别为1.676±0.766(ng/ml)、2.150±0.714(ng/ml)、2.417±0.537(ng/ml)。急、慢性乙肝组CXCL16浓度显著高于对照组(P值分别为0.015、0.000)。急、慢性乙肝组之间比较,差异无统计学意义(P=0.142)。HBeAg阳性乙肝组(n=26)与HBeAg阴性乙肝组(n=30)比较,差异无统计学意义(P=0.741)。CXCL16浓度与ALT水平无相关性(r=-0.46,P=0.736),与HBVDNA拷贝数也无相关性(r=-0.191,P=0.158),但CXCL16有随病情加重而增高的趋势。结论CXCL16可能参与了乙肝的炎症损伤机制;ALT、HBVDNA及HBeAg与CXCL16浓度变化无明显相关。Abstract: Objective To investigate the change and clinical significance of serous chemokine CXCL16 in patients with hepatitis B.Methods The serous concentration of CXCL16 was detected by enzyme linked immunosorbent assay (ELISA) ;HBV-DNA was detected by fluorescent quantitive polymerase chain reaction (FQ-PCR) ;Liver function was assayed by automatic biochemistry analyzer.Results Concentration of serous CXCL16 in normal group (n=25) 、AHB (acute hepatitis B) group (n=24) and CHB (chronic hepatitis B) group (n=32) was 1.676±0.766 (ng/ml) 、2.150±0.714 (ng/ml) and 2.417±0.537 (ng/ml) respectively.The concentration of CXCL16 in AHB and CHB groups were both significantly higher than that of normal group, (P=0.015, 0.000, respectively) .However, the disparity of CXCL16 concentration between AHB and CHB group isn't statistically significant (P=0.142) .Likewise, no statistical significance of the difference of CXCL16 was found between HBeAg positive (n=26) and negative (n=30) patients group (P=0.741) .There is no correlation between the concentration of CXCL16 and the level of ALT (r=-0.46, P=0.7365) , so as the association of CXCL16 and HBVDNA (r=-0.191, P=0.158) .Nevertheless, the concentration of CXCL16 is raised as the pathogenetic condition aggravated.Conclusion It is possible that CXCL16 play a role in liver inflammatory in hepatitis B.The change of the serous concentration of CXCL16 isn't evidently related with that of ALT、HBVDNA and HBeAg.
-
Key words:
- chemokine /
- CXCL16 /
- hepatitis B
-
[1]Kunkel E J, Boisvert J, Murphy K, et al.Expression of the Chemo-kine Receptors CCR4, CCR5, and CXCR3 by Human Tissue-Infil-trating Lymphocytes[J].Am J Phathol, 2002, 160 (1) ∶347-355. [2]Matloubian M, David A, Engel S, et al.Atransmembane CXC Che-mokine is a ligand for HIV-coreceptor BONZO[J].Nat Immunol, 2000, 1 (4) ∶298-304. [3]Heydtmann M, Lalor P, Ekstan J, et al.CXC Chemokine Ligand 16Promotes Integrin-Mediated Adhesion of Liver-Infiltrating Lym-phocytes to Chlangioicytes and Hepatocytes within the Inflamed Hu-man Liver[J].J Immunol, 2005, 174∶1055-1062. [4]中华医学会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19 (1) ∶56. [5]吴玉章.基础免疫学[M].北京:科学出版社, 2003∶871-872. [6]Loetscher M, Gerber B.Chemokine receptor specific for IP-10 andMig:structure, function, and expression in activatedT-lymphocytes[J].J Exp Med, 1996, 184∶963-969. [7]Peter J, Kyle J, Paul T, et al.A Disintegin and Metalloproteinase10-Mediated Cleavage and Shedding Regulates the Cell Surface Ex-pression of CXC Chemokine Ligand 16[J].J Immunol, 2004, 172∶3678-3685. [8]彭文伟.传染病学[M].第六版, 北京:人民卫生出版社, 2003∶31.
本文二维码
计量
- 文章访问数: 2256
- HTML全文浏览量: 14
- PDF下载量: 850
- 被引次数: 0